Skip Nav Destination
Letter|
August 5, 2024
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
Esteban Arrieta-Bolaños
German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany
https://orcid.org/0000-0002-3696-5803
Search for other works by this author on:
Lars L. J. van der Burg
Lars L. J. van der Burg
Leiden University Medical Center, Leiden, Netherlands
Search for other works by this author on:
Tobias Gedde-Dahl
Tobias Gedde-Dahl
Oslo University Hospital, Rikshospitalet, Oslo, Norway
Search for other works by this author on:
Marie Robin
Marie Robin
Hopital Saint Louis, Paris, France
Search for other works by this author on:
Nicolaus Kröger
Nicolaus Kröger
University Medical Center Hamburg, Germany
Search for other works by this author on:
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha
CHU de Lille
Search for other works by this author on:
Anne Huynh
Anne Huynh
CHU - Institut Universitaire du Cancer Toulouse
Search for other works by this author on:
Eric Deconinick
Eric Deconinick
Hopital Jean Minjoz, France
Search for other works by this author on:
Joost G. K. van der Hem
Joost G. K. van der Hem
Leiden University Medical Center, Leiden, Netherlands
Search for other works by this author on:
Liesbeth C. de Wreede
Liesbeth C. de Wreede
DKMS Clinical Trials Unit, Germany
Search for other works by this author on:
Florent Malard
Florent Malard
Cellular Therapy and Immunobiology Working Party of the EBMT, Netherlands
Search for other works by this author on:
Katharina Fleischhauer
Katharina Fleischhauer
German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany
Search for other works by this author on:
Blood blood.2024024351.
Article history
Submitted:
February 20, 2024
Revision Received:
July 22, 2024
Accepted:
July 22, 2024
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal